ONCOLife Articles
Giredestrant Plus Everolimus Improves PF Survival in ER+ Advanced Breast Cancer
ONCOLife | 26 September 2025
The V Foundation and CVC Collaborate to Advance Breast Cancer Vaccine Research
ONCOLife | 12 September 2025
NEJM Study Confirms Low-Dose Aspirin Halves Recurrence in Colorectal Cancer
Clinical Trials | 20 September 2025
Sugary Drinks Drive Colorectal Cancer Metastasis via SORD Pathway, Study Finds
ONCOLife | 20 September 2025
FDA Grants Breakthrough Status to Raludotatug Deruxtecan for Refractory Ovarian Cancer
ONCOLife | 17 September 2025
The Role of Third-Generation TKIs in Overcoming Chronic Myeloid Leukemia Resistance
ONCOLife | 17 September 2025
SUNMO Trial: A New Chapter for Transplant-Ineligible Large B-Cell Lymphoma
ONCOLife | 15 September 2025
The V Foundation for Cancer Research and CVC Partner to Accelerate Breast Cancer Vaccines
ONCOLife
29 August 2025
FDA Grants Breakthrough Status to Izalontamab Brengitecan for EGF+ Lung Cancer
FDA & EMA
20 August 2025
First Patient Enrolled for Aliya® PEF Tumor Ablation of Lung/Liver Soft-Tissue Lesions
ONCOLife
18 August 2025
Ferroptosis as a New Strategy: Iron-Driven Cell Death Targets Cancer Stem Cells
ONCOLife
17 August 2025
Redesigned CD40 Antibody Triggers Systemic Tumor Regression and Complete Remission
ONCOLife
15 August 2025
RNA Isoform RUNX1C Identified as Molecular 'Switch' Behind Chemoresistance in Blood Cancer
ONCOLife
16 August 2025
Bacteria Cloak Viruses to Safely Deliver Cancer-Killing Payloads into Solid Tumors
ONCOLife
16 August 2025
mRNA Vaccines Plus Checkpoint Inhibitors Shows Curative Potential in Gastric Cancer
ONCOLife
15 August 2025
PADCEV–KEYTRUDA Combination Delivers Survival Gains in High-Risk Bladder Cancer
ONCOLife
12 August 2025
Genetic Testing Boosts Safety, Reduces Chemotherapy Side Effects in GI Cancer
ONCOLife
9 August 2025
Epcoritamab + R2 Achieves 95.7% ORR, Cuts Risk by 79% in R/R Follicular Lymphoma
ONCOLife
8 August 2025
FDA Approves Modeyso as First-Ever Therapy for Pediatric Brain Tumor, H3 K27M+ Glioma
FDA & EMA
6 August 2025
ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is dedicated to covering key developments in the field of oncology. We delve into the stories behind significant clinical research and drug developments, highlight the latest news, and offer exclusive interviews.
